X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6635) 6635
Conference Proceeding (284) 284
Book Chapter (67) 67
Dissertation (30) 30
Publication (11) 11
Magazine Article (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancellous bone (4641) 4641
humans (3177) 3177
female (2191) 2191
animals (2145) 2145
male (1805) 1805
osteoporosis (1680) 1680
trabecular bone (1526) 1526
endocrinology & metabolism (1406) 1406
bones (1404) 1404
bone (1370) 1370
orthopedics (1370) 1370
engineering, biomedical (1241) 1241
aged (1193) 1193
middle aged (1188) 1188
bone density (1143) 1143
density (1127) 1127
analysis (906) 906
biomechanical phenomena (859) 859
cortical bone (846) 846
mechanical-properties (844) 844
adult (803) 803
stress, mechanical (756) 756
mineral density (692) 692
surgery (674) 674
aged, 80 and over (652) 652
fractures (648) 648
rats (636) 636
biomechanics (623) 623
strength (620) 620
models, biological (587) 587
femur (570) 570
mechanical properties (561) 561
finite element analysis (554) 554
bone density - physiology (503) 503
computer simulation (495) 495
architecture (487) 487
biophysics (485) 485
postmenopausal women (479) 479
computed tomography (474) 474
mice (415) 415
x-ray microtomography (413) 413
porosity (405) 405
elasticity (402) 402
bone and bones - physiology (400) 400
tomography, x-ray computed (386) 386
materials science, biomaterials (380) 380
dentistry, oral surgery & medicine (373) 373
anisotropy (371) 371
in-vitro (371) 371
bone mineral density (370) 370
biomedical materials (351) 351
medicine & public health (351) 351
knochen (342) 342
research (335) 335
ovariectomy (330) 330
bone and bones - diagnostic imaging (327) 327
osteogenesis (324) 324
histomorphometry (320) 320
cancellous bone - diagnostic imaging (317) 317
rats, sprague-dawley (314) 314
elastic properties (305) 305
behavior (304) 304
bone remodeling (302) 302
collagen (302) 302
bone density - drug effects (300) 300
cell biology (299) 299
in-vivo (299) 299
finite element method (296) 296
compressive strength (294) 294
dentistry (294) 294
spine (293) 293
biocompatibility (291) 291
fracture (288) 288
microstructure (285) 285
tomography (285) 285
radiography (284) 284
rheumatology (280) 280
bone and bones - pathology (279) 279
cattle (278) 278
proximal femur (276) 276
computed-tomography (274) 274
age (271) 271
bone transplantation - methods (271) 271
mathematical models (271) 271
algorithms (269) 269
absorptiometry, photon (268) 268
physiological aspects (266) 266
radiology, nuclear medicine & medical imaging (265) 265
studies (265) 265
acoustics (258) 258
osteoarthritis (252) 252
disease models, animal (251) 251
endocrinology (251) 251
femur - diagnostic imaging (250) 250
microarchitecture (250) 250
bone and bones - anatomy & histology (247) 247
femur - physiology (243) 243
iliac crest (243) 243
tomography, x-ray computed - methods (240) 240
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6786) 6786
Japanese (107) 107
German (103) 103
Chinese (34) 34
Portuguese (28) 28
Korean (22) 22
French (20) 20
Spanish (9) 9
Czech (8) 8
Russian (5) 5
Italian (3) 3
Hungarian (2) 2
Turkish (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0175329
Teriparatide [human parathyroid hormone (1-34)], which exerts an anabolic effect on bone, is used for the treatment of osteoporosis in patients who are at a high risk for fracture... 
HUMAN PARATHYROID HORMONE(1-34) | MARROW FIBROSIS | OVARIECTOMIZED CYNOMOLGUS MONKEYS | VERTEBRAL FRACTURES | THINNER CORTICES | DISTAL RADIUS | MULTIDISCIPLINARY SCIENCES | TURNOVER MARKERS | POSTMENOPAUSAL WOMEN | FIBROUS DYSPLASIA | MECHANICAL-PROPERTIES | Osteogenesis - physiology | X-Ray Microtomography | Bone and Bones - drug effects | Dose-Response Relationship, Drug | Collagen - drug effects | Bone and Bones - diagnostic imaging | Bone and Bones - metabolism | Biomechanical Phenomena - drug effects | Bone Resorption - metabolism | Female | Models, Animal | Bone Resorption - chemically induced | Porosity - drug effects | Imaging, Three-Dimensional | Bone and Bones - cytology | Rabbits | Bone Density Conservation Agents - adverse effects | Drug Administration Schedule | Teriparatide - administration & dosage | Teriparatide - blood | Osteogenesis - drug effects | Bone Density Conservation Agents - administration & dosage | Microscopy, Interference | Bone Density Conservation Agents - blood | Collagen - metabolism | Animals | Bone Resorption - pathology | Teriparatide - adverse effects | Microscopy, Fluorescence | Adaptations | Animal models | Spine | Bone (trabecular) | Bisphosphonates | Clinical outcomes | Bone resorption | Proteins | Osteoporosis | Alendronic acid | Bone growth | Computed tomography | Fibrous dysplasia | Bone marrow | Bone dysplasia | Tunneling | Skeleton | Bone density | Bone loss | Bone (cortical) | Drug therapy | Bone strength | Drug dosages | Age | Bone remodelling | Rats | Risk reduction | Endocrine therapy | Pharmacology | Frost | Bone turnover | Metabolism | Bone mass | Fractures | Osteodystrophy | Mice | Bone mineral density | Mutation | Porosity | Pharmacokinetics | Risk management | Kidney transplantation | Bone (cancellous)
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 2017, Volume 32, Issue 10, pp. 2010 - 2021
...; the reversibility of the bone lost at the weight-bearing bone sites is not established, although it is suspected to take longer than the mission length... 
MICROGRAVITY | Radius/anatomy & histology | Tibia/anatomy & histology | Cortical Bone/anatomy & histology | Humans | Middle Aged | Bone Density/physiology | Tomography, X-Ray Computed | Endocrinology, Diabetes and Metabolism | SPACEFLIGHT | Space Flight | BONE HR-pQCT | PERIOSTIN | Journal Article | Walking | Biomechanical Phenomena | BONE RECOVERY | Orthopedics and Sports Medicine | Cancellous Bone/anatomy & histology | Adult | Biomarkers/blood | Weight-Bearing | BONE HR‐pQCT | VIVO HR-PQCT | QUANTITATIVE COMPUTED-TOMOGRAPHY | MINERAL DENSITY | ESTIMATED STRENGTH | LONG-DURATION SPACEFLIGHT | DISTAL RADIUS | MICROARCHITECTURE | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | BED REST | AGE | Cancellous Bone - physiopathology | Bone Density - physiology | Tibia - physiology | Radius - physiology | Cortical Bone - physiopathology | Tibia - diagnostic imaging | Tibia - anatomy & histology | Biomarkers - blood | Radius - anatomy & histology | Cortical Bone - anatomy & histology | Cancellous Bone - diagnostic imaging | Cancellous Bone - anatomy & histology | Cortical Bone - diagnostic imaging | Radius - diagnostic imaging | Osteoporosis | Analysis | Bones | Astronauts | Porosity | Density | Space stations | Radius | SOST protein | Space flight | Weightlessness | Bone (trabecular) | Bone resorption | Bone growth | Bone mass | Multinational space ventures | Computed tomography | Tibia | Bone density | Bone (cortical)
Journal Article
PloS one, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0177416
To improve the safe use of allograft bone, decellularization techniques may be utilized to produce acellular scaffolds... 
CORTICAL BONE | MATRIX | WOMEN | SITE | ALLOGRAFT | MULTIDISCIPLINARY SCIENCES | ARCHITECTURE | OSTEOGENIC DIFFERENTIATION | POTENTIAL IMPLICATIONS | MESENCHYMAL STEM-CELLS | GROWTH-FACTOR-I | Cell Proliferation | Age Factors | Humans | Middle Aged | Transcriptome | Culture Media, Conditioned - pharmacology | Male | Tissue Scaffolds | Cell Differentiation - genetics | Bone and Bones - diagnostic imaging | Bone and Bones - metabolism | Mesenchymal Stem Cells - cytology | Mesenchymal Stem Cells - drug effects | Aged, 80 and over | Adult | Female | Mesenchymal Stem Cells - metabolism | Osteogenesis - genetics | Bone Density | Bone Regeneration | Radiography | Cell Differentiation - drug effects | Bone Transplantation | Biomarkers | Aged | Tissue Donors | Culture Media, Conditioned - metabolism | Bones | Bone-grafting | Growth | Health aspects | Patient outcomes | Osseointegration | Health services | Carbon dioxide | Bone (trabecular) | Bone surgery | Blood | Proteins | Osteoporosis | Pore size | Bone growth | Surgery | Topography | Bone marrow | Aging | Bone (cortical) | Bone matrix | Bone composition | Autografts | Longevity | Bone healing | Bioavailability | Metabolism | Insulin | Chemicals | Studies | Immunogenicity | Quality control | Stem cells | Osteoarthritis | Endocrinology | Age composition | Bone (cancellous) | Adherent cells | Osteoprogenitor cells | Animal models | Calcium | Biology | Arthritis | Insulin-like growth factors | Engineering | Allografts | Rodents | Extracellular matrix | Bone loss | Age | Immune response | Bone morphogenetic protein 2 | Tissue engineering | Complications | Bioassays | Feasibility studies | Hip | Medicine | Skin & tissue grafts | Porosity | Bone morphogenetic protein 9
Journal Article
Bone, ISSN 8756-3282, 2016, Volume 93, pp. 86 - 96
Abstract Odanacatib (ODN) a selective and reversible cathepsin K inhibitor, inhibits bone resorption, increases bone mass and reduces fracture risk in women with osteoporosis. A 16-month... 
Orthopedics | Osteoporosis | Odanacatib | Bone remodeling | Alendronate | Bone strength | Cathepsin K inhibitor | CORTICAL BONE | RESORPTION | K INHIBITOR ODANACATIB | COMPUTED-TOMOGRAPHY | HIP | MINERAL DENSITY | SPINE | ENDOCRINOLOGY & METABOLISM | ESTROGEN | POSTMENOPAUSAL WOMEN | MONKEYS | Bone and Bones - pathology | Femur - pathology | Tomography, X-Ray Computed | Cancellous Bone - drug effects | Cortical Bone - pathology | Femur - diagnostic imaging | Biphenyl Compounds - therapeutic use | Bone Remodeling - drug effects | Bone and Bones - drug effects | Bone Diseases, Metabolic - drug therapy | Cancellous Bone - diagnostic imaging | Biphenyl Compounds - pharmacology | Bone and Bones - diagnostic imaging | Cancellous Bone - pathology | Female | Lumbar Vertebrae - physiopathology | Disease Models, Animal | Biomarkers - metabolism | Rabbits | Cancellous Bone - physiopathology | Bone Diseases, Metabolic - diagnostic imaging | Ovariectomy | Cortical Bone - physiopathology | Lumbar Vertebrae - drug effects | Femur - physiopathology | Withholding Treatment | Absorptiometry, Photon | Regression Analysis | Biomechanical Phenomena | Bone Density - drug effects | Bone and Bones - physiopathology | Organ Size - drug effects | Animals | Lumbar Vertebrae - pathology | Bone Diseases, Metabolic - physiopathology | Cortical Bone - diagnostic imaging | Cathepsins | Aluminum compounds | Bones | Density | Analysis
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 09/2012, Volume 27, Issue 9, pp. 1936 - 1950
Like bone mass, bone quality is specified in development, actively maintained postnatally, and disrupted by disease... 
MATRIX METALLOPROTEINASE–13 | OSTEOCYTE | REMODELING | FRACTURE RESISTANCE | BONE QUALITY | OSTEOCYTE PERILACUNAR REMODELING | BONE MATRIX | MATRIX METALLOPROTEINASE-13 | CORTICAL BONE | BIOCHEMICAL MARKERS | CALCIUM DEFICIENCY | MECHANICAL-PROPERTIES | GROWTH-FACTOR-BETA | BIOMECHANICAL PROPERTIES | 1-YEAR TREATMENT | CANCELLOUS BONE | AGE-RELATED-CHANGES | NONENZYMATIC GLYCATION | ENDOCRINOLOGY & METABOLISM | Bone Matrix - metabolism | Lactation | Bone Matrix - diagnostic imaging | Osteocytes - enzymology | X-Ray Microtomography | Tibia - pathology | Matrix Metalloproteinase 13 - deficiency | Fractures, Bone - enzymology | Female | Fractures, Bone - diagnostic imaging | Tibia - physiopathology | Tibia - enzymology | Bone Resorption - physiopathology | Osteoclasts - pathology | Tibia - diagnostic imaging | Organ Size | Osteoclasts - metabolism | Bone Matrix - pathology | Matrix Metalloproteinase 13 - metabolism | Protein Transport | Bone Resorption - diagnostic imaging | Collagen - metabolism | Osteoblasts - pathology | Biomechanical Phenomena | Animals | Calcification, Physiologic | Bone Resorption - pathology | Fractures, Bone - physiopathology | Osteocytes - pathology | Fractures, Bone - pathology | Mice | Osteoblasts - metabolism | Bone Remodeling | Osteogenesis | Biological products | Fractures | Phosphatases | Collagen | Analysis | Stem cells | Bones | Health aspects | Density | Bone remodelling | Mechanical properties | Osteocytes | SOST protein | Matrix metalloproteinase | Collagenase 3 | Osteoblasts | Diaphysis | Bone histomorphometry | Bone mass | Molecular modelling | Cross-linking | Extracellular matrix | Osteoclasts | Acid phosphatase (tartrate-resistant) | Bone loss | Bone matrix | matrix metalloproteinase-13 | remodeling | fracture resistance | bone matrix | osteocyte | bone quality | osteocyte perilacunar remodeling
Journal Article
PloS one, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e34647
.... The GC related disruption of bone marrow microcirculation and increased adipogenesis contribute to GIO development... 
TRABECULAR BONE | CELLS | GLUCOCORTICOIDS | HISTOMORPHOMETRY | MULTIDISCIPLINARY SCIENCES | OSTEOBLASTS | BEAGLE | DIFFERENTIATION | EXPRESSION | OSTEONECROSIS | MILTIORRHIZA | Neovascularization, Physiologic - drug effects | Gene Expression - drug effects | Adipogenesis - drug effects | Benzofurans - administration & dosage | Male | Adipocytes - drug effects | PPAR gamma - metabolism | Core Binding Factor Alpha 1 Subunit - metabolism | Bone and Bones - drug effects | Intercellular Signaling Peptides and Proteins - metabolism | Bone Morphogenetic Proteins - metabolism | Osteoporosis - metabolism | Bone and Bones - metabolism | Stromal Cells - drug effects | Bone Marrow Cells - drug effects | Cell Differentiation | Bone Morphogenetic Proteins - genetics | PPAR gamma - genetics | Prednisone - administration & dosage | Benzofurans - therapeutic use | Osteoporosis - chemically induced | Prednisone - adverse effects | Osteoporosis - prevention & control | Osteoblasts - drug effects | Osteogenesis - drug effects | Stromal Cells - metabolism | Bone and Bones - blood supply | Intercellular Signaling Peptides and Proteins - genetics | Rats | Rats, Sprague-Dawley | beta Catenin - metabolism | beta Catenin - genetics | Animals | Adipocytes - metabolism | Osteoblasts - metabolism | Bone Marrow Cells - metabolism | Core Binding Factor Alpha 1 Subunit - genetics | Osteoporosis | Corticosteroids | Bones | Prednisone | Cell differentiation | Density | Steroids | Oxidative stress | Transcription factors | Glucocorticoids | Laboratories | Differentiation (biology) | Stimulation | Adipocytes | Inflammatory diseases | β-catenin | Angiogenesis | Bone histomorphometry | Biomedical materials | Bone growth | Ischemia | Rodents | Bone marrow | Biocompatibility | Inhibition | Bone loss | Bone strength | Osteopenia | Adipogenesis | Cbfa-1 protein | Research & development--R&D | Medical treatment | Pharmacology | Gene expression | Medicine | Studies | Herbal medicine | Osteoblastogenesis | Bone mass | Acids | Stem cells | Dilation | Bone mineral density | In vivo methods and tests | Dkk1 protein | Osteogenesis | Bone (cancellous) | Apoptosis | Herbal medicines | Guanylate cyclase | Osteoblasts | adipogenesis | stromal cells | Bone morphogenetic proteins | Differentiation | Research & development | R&D
Journal Article
BioMed research international, ISSN 2314-6133, 12/2017, Volume 2017, pp. 3905216 - 10
Rationale. Radium-223-Dichloride (Ra-223) is an alpha-emitter, used to treat bone metastases... 
MEDICINE, RESEARCH & EXPERIMENTAL | RADIUM-223 DICHLORIDE | EFFICACY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DOUBLE-BLIND | PATTERNS | SEEKING | TOXICITY | PHASE-3 | PLANAR | DOCETAXEL | CHEMOTHERAPY | Blood Platelets - radiation effects | Leukocytes - pathology | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - radiotherapy | Bone Marrow Diseases - etiology | Cancellous Bone - metabolism | Hemoglobins - radiation effects | Tumor Burden - radiation effects | Humans | Middle Aged | Bone Neoplasms - secondary | Hemoglobinuria, Paroxysmal - radiotherapy | Hemoglobinuria, Paroxysmal - etiology | Male | Bone Marrow - radiation effects | Hemoglobinuria, Paroxysmal - pathology | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Leukocytes - radiation effects | Anemia, Aplastic - etiology | Neoplasm Invasiveness - pathology | Anemia, Aplastic - radiotherapy | Bone Marrow - metabolism | Aged, 80 and over | Cancellous Bone - pathology | Anemia, Aplastic - pathology | Prostatic Neoplasms - pathology | Radium - administration & dosage | Cancellous Bone - radiation effects | Radioisotopes - adverse effects | Hemoglobins - metabolism | Radium - adverse effects | Bone Marrow Diseases - pathology | Bone Neoplasms - radiotherapy | Bone Marrow - pathology | Radioisotopes - administration & dosage | Bone Marrow Diseases - radiotherapy | Aged | Prostatic Neoplasms - complications | Care and treatment | Cancer patients | Algorithms | Hemoglobin | Metastasis | Health aspects | Prostate cancer | Patient compliance | Cancer | Nuclear medicine | Correlation | Toxicity | Bone tumors | Leukocytes | Bone (trabecular) | Cancer therapies | Metastases | Mathematical analysis | Bone marrow | Emitters | Failure | Radium | Radiation therapy | Metabolism | Patients | Single photon emission computed tomography | White blood cells | Bone cancer | Computer applications | Bone (long) | Platelets | Prostate
Journal Article
Osteoporosis international, ISSN 1433-2965, 2016, Volume 28, Issue 1, pp. 309 - 320
In contrast to previously reported elevations in serum sclerostin levels in diabetic patients, the present study shows that the impaired bone microarchitecture and cellular turnover associated... 
Type 2 diabetes | Medicine & Public Health | Orthopedics | Rheumatology | Sclerostin | Bone | Zucker rats | Endocrinology | CELLS | BONE-MINERAL DENSITY | STRENGTH | RAT MODEL | IN-VITRO | INHIBITION | MASS | ENDOCRINOLOGY & METABOLISM | HIGH GLUCOSE | MICE | GLYCATION END-PRODUCTS | Blood Glucose - physiology | Bone Density - physiology | Bone Morphogenetic Proteins - physiology | Male | Bone Morphogenetic Proteins - blood | Bone Remodeling - physiology | Diabetes Mellitus, Experimental - blood | Cancellous Bone - diagnostic imaging | Bone Morphogenetic Proteins - genetics | Diabetes Mellitus, Experimental - physiopathology | Cancellous Bone - physiopathology | Osteocytes - metabolism | RNA, Messenger - genetics | Cells, Cultured | Cortical Bone - physiopathology | Hardness | X-Ray Microtomography - methods | Adipocytes - pathology | Rats, Zucker | Diabetes Mellitus, Type 2 - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Genetic Markers - genetics | Genetic Markers - physiology | Blood Glucose - metabolism | Body Weight - physiology | Cortical Bone - diagnostic imaging | Complications and side effects | Physiological aspects | Glycoproteins | Bone diseases | Research | Risk factors | Immunohistochemistry | Bone remodelling | Diabetes mellitus | mRNA | SOST protein | Bone turnover | Bone (trabecular) | Serum levels | Bone histomorphometry | Bone growth | Bone mass | Fractures | Computed tomography | Rodents | Osteoclasts | Bone mineral density | Acid phosphatase (tartrate-resistant) | Bone density | Diabetes | Bone (cortical) | Diabetes mellitus (non-insulin dependent) | Osteogenesis | Enzyme-linked immunosorbent assay | Genotypes | Life Sciences | Original
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 02/2017, Volume 22, Issue 2, pp. 197 - 197
...) exhibited significant antiosteoporotic effects on OVX mice, evidenced by enhanced bone strength, bone mineral density and improved trabecular bone microarchitecture... 
Cistanoside A | RANKL | Antiosteoporotic | Ovariectomized mice | TRAF6 | ANTIOSTEOPOROTIC ACTIVITY | DIAGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | antiosteoporotic | OSTEOPOROSIS | cistanoside A | ovariectomized mice | OSTEOBLASTS | PHENYLETHANOIDS | ECHINACOSIDE | EXTRACT | Bone and Bones - pathology | Mechanical Phenomena - drug effects | Cancellous Bone - metabolism | Ovariectomy | Osteogenesis - drug effects | Osteoporosis - drug therapy | Cancellous Bone - drug effects | Glycosides - pharmacology | Osteoporosis - etiology | X-Ray Microtomography | Bone and Bones - drug effects | Bone Density - drug effects | Animals | Cancellous Bone - diagnostic imaging | Osteoporosis - metabolism | Osteoporosis - pathology | Bone and Bones - diagnostic imaging | Bone and Bones - metabolism | Biomarkers | Bone Resorption - metabolism | Cancellous Bone - pathology | Catechols - pharmacology | Female | Mice | Intervention | Alkaline phosphatase | Body weight | AKT protein | Bone (trabecular) | Inactivation | Phosphatase | Osteoprotegerin | Bone resorption | Osteoporosis | Bone growth | Rodents | Deoxypyridinoline | TRANCE protein | Bone strength | NF-κB protein | Cathepsin K | TRAF6 protein | Bone turnover | Metabolism | Biological activity | 1-Phosphatidylinositol 3-kinase | Molecular modelling | Lymphocytes B | Tumor necrosis factor | Ligands | Bone mineral density | Acid phosphatase (tartrate-resistant) | Osteogenesis
Journal Article
Journal of biomedical materials research. Part B, Applied biomaterials, ISSN 1552-4973, 02/2019, Volume 107, Issue 2, pp. 408 - 414
Journal Article
Bone, ISSN 8756-3282, 2016, Volume 93, pp. 33 - 42
.... Testosterone is a potentially appealing strategy to prevent simultaneous bone and muscle loss... 
Orthopedics | Testosterone | Androgens | Muscle | Conditional knock-out mice | Disuse osteoporosis | Androgen receptor | CORTICAL BONE | DEGRADES BONE | OSTEOGENIC RESPONSE | BOTULINUM TOXIN | RAT MODEL | SKELETAL-MUSCLE | BONE LOSS | ADULT MALE-MICE | ESTROGEN-RECEPTOR-ALPHA | ENDOCRINOLOGY & METABOLISM | SPINAL-CORD-INJURY | Muscular Disorders, Atrophic - complications | Body Weight | Receptors, Androgen - metabolism | Bone Diseases, Metabolic - pathology | Male | Muscular Disorders, Atrophic - physiopathology | Cancellous Bone - drug effects | Cortical Bone - pathology | X-Ray Microtomography | Bone Remodeling - drug effects | Muscular Disorders, Atrophic - drug therapy | Bone Diseases, Metabolic - drug therapy | Cancellous Bone - diagnostic imaging | Muscular Atrophy - physiopathology | Bone Diseases, Metabolic - complications | Gene Deletion | Cancellous Bone - pathology | Androgens - therapeutic use | Female | Integrases - metabolism | Muscular Disorders, Atrophic - pathology | Muscular Atrophy - complications | Extracellular Matrix Proteins - metabolism | Acute Disease | Bone Resorption - physiopathology | Cancellous Bone - physiopathology | Mice, Inbred C57BL | Muscular Atrophy - pathology | Bone Resorption - drug therapy | Cortical Bone - physiopathology | Organ Size | Bone Resorption - complications | MyoD Protein - metabolism | Muscular Atrophy - drug therapy | Animals | Androgens - pharmacology | Calcification, Physiologic | Bone Resorption - pathology | Cortical Bone - drug effects | Bone Diseases, Metabolic - physiopathology | Cortical Bone - diagnostic imaging | Osteoporosis | Paralysis | Body weight
Journal Article